Focusing on quality patient care in the new global subsidy for malaria medicines

PLoS Medicine

Volumn 6, Issue 7, 2009, Pages

  Moon, Suerie ^c   Casas, Carmen Pérez ^a   Kindermans, Jean Marie ^b   De Smet, Martin ^b   Von Schoen Angerer, Tido ^a  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b MÉDECINS SANS FRONTIÈRES   (Belgium)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE PLUS ARTESUNATE; ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; ARTESUNATE; CHLOROQUINE; FANSIDAR; MEFLOQUINE;

COMBINATION CHEMOTHERAPY; DIAGNOSTIC TEST; DRUG COST; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; MALARIA; MALARIA FALCIPARUM; MONOTHERAPY; PARASITE IDENTIFICATION; PATIENT CARE; PATIENT COMPLIANCE; REVIEW; SOCIAL SUPPORT; WORLD HEALTH ORGANIZATION;

ANTIMALARIALS; ARTEMISININS; DELIVERY OF HEALTH CARE; DRUG THERAPY, COMBINATION; FINANCING, ORGANIZED; HEALTH SERVICES ACCESSIBILITY; HUMANS; INTERNATIONAL COOPERATION; MALARIA, FALCIPARUM; QUALITY OF HEALTH CARE; WORLD HEALTH;

EID: 68049142385     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1000106     Document Type: Review

References (40)

1. World Health Organization (2001) The use of antimalarial drugs: Report of an informal consultation, 13-17 Nov 2000. WHO/CDS/RBM/2001.33. Available: http://www.who.int/malaria/cmc-upload/0/000/014/923/use-of-antimalarials.pdf. Accessed 29 April 2009.
2. World Health Organization (2008) World malaria report 2008. WHO/HTM/GMP/2008.1. Available: http://www.who.int/malaria/wmr2008/. Accessed 29 April 2009.
3. Yeung S, Van Damme W, Socheat D, White N, Mills A (2008) Access to artemisinin combination therapy for malaria in remote areas of Cambodia. Malar J 7: 96.
4. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, et al. (2008) Evidence of artemisinin-resistant malaria in Western Cambodia. N Engl J Med 359: 2619-2620.
5. World Health Organization (2008) Global malaria control and elimination: Report of a meeting on containment of artemisinin tolerance, 19 January 2008. Available: http://www.who.int/malaria/docs/drugresistance/Malaria-Artemisinin. pdf. Accessed 29 April 2009.
6. Bosman A, den Besten H, Cutler M, Pilloy J, Singh I, et al. (2008) Technical paper to ensure sustainable API supply to meet global ACT demand. Discussed at Roll Back Malaria Procurement and Supply Management Working Group Meeting on 9 December 2008.
7. Connor J, Rafter N, Rodgers A (2004) Do fixed-dose combination pills or unit-of-use packaging improve adherence? A systematic review. Bull World Health Organ 82: 935-939.
8. Moulding T, Dutt AK, Reichman LB (1995) Fixed-dose combinations of antituberculous medications to prevent drug resistance. Ann Intern Med 122: 951-954.
9. Laurent C, Kouanfack C, Koulla-Shiro S, Nkoué N, Bourgeois A, et al. (2004) Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: Open-label multicentre trial. Lancet 364: 29-34.
10. World Health Organization (2009) WHO list of prequalified medicinal products. Available: http://healthtech.who.int/pq/. Accessed 29 April 2009.
11. The Global Fund to Fight AIDS, Tuberculosis and Malaria (2009) Guidelines for applications - AMFm phase 1. Available: http://www.theglobalfund.org/ documents/amfm/1/AMFm-Phase-1-Guidelines-for-Applications.pdf. Accessed 29 April 2009.
12. Shillcutt S, Morel C, Goodman C, Coleman P, Bell D, et al. (2008) Cost-effectiveness of malaria diagnostic methods in sub-Saharan Africa in an era of combination therapy. Bull World Health Organ 86: 101-110.
13. Medecins Sans Frontieres (2008) Full prescription: Better malaria treatment for more people, MSF's experience. Available: http://www.msf.org/ source/medical/malaria/2008/MSF-malaria-2008.pdf. Accessed 29 April 2009.
14. Källander K, Hildenwall H, Waiswa P, Galiwango E, Peterson S, et al. (2008) Delayed care seeking for fatal pneumonia in children under five years in Uganda: A case-series study. Bull World Health Organ 86: 322-328.
15. Brent AJ, Ahmed I, Ndiritu M, Lewa P, Ngetsa C, et al. (2006) Incidence of clinically significant bacteraemia in children who present to hospital in Kenya: Community-based observational study. Lancet 367: 482-488.
16. Lubell Y, Reyburn H, Mbakilwa H, Mwangi R, Chonya S, et al. (2008) The impact of response to the results of diagnostic tests for malaria: Cost-benefit analysis. BMJ 336: 202-205.
17. Hamer DH, Ndhlovu M, Zurovac D, Fox M, Yeboah-Antwi K, et al. (2007) Improved diagnostic testing and malaria treatment practices in Zambia. JAMA 297: 2227-2231.
18. Drakeley C, Reyburn H (2009) Out with the old, in with the new: The utility of rapid diagnostic tests for malaria diagnosis in Africa. Trans R Soc Trop Med Hyg 103: 333-337.
19. Bell D, Wongsrichanalai C, Barnwell JW (2006) Ensuring quality and access for malaria diagnosis: How can it be achieved? Nat Rev Microbiol 4: 682-695.
20. World Health Organization (2008) Update on WHO procedures for procurement and quality assurance of malaria rapid diagnostic tests. Available: http://www.wpro.who.int/NR/rdonlyres/3659F207-C0B3-4D59-83BD-446CD9847ED1/0/ WHOmalariaQAupdate-052008.pdf. Accessed 29 April 2009.
21. World Health Organization, UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, Centers for Disease Control, Foundation for Innovative New Diagnostics (2009) Malaria rapid diagnostic test performance: Results of WHO product testing of malaria RDTs: Round 1 (2008). Available: http://www.wpro.who.int/NR/rdonlyres/ED81BDE9-B812-4B80-8408- 3A129A6365C4/0/OMSFINDRapportMalaria200900514v25.pdf. Accessed 28 June 2009.
22. Medecins Sans Frontières/Operational Center Brussels (2008) Améliorer l'accès au traitements efficaces contre le paludisme au Mali: Expérience positive de réduction de la barrière financière pour les patients dans le cercle de Kangaba. Available: http://www.msf.or.jp/info/pressreport/pdf/Mali-malaria2008.pdf. Accessed 29 April 2009.
23. Ngo DT, Erhart A, Xuan HL, Khanh TL, Xuan XN, et al. (2009) Rapid decrease of malaria morbidity following the introduction of community based monitoring in rural areas of central Vietnam. Malaria J 8: 3.
24. Médecins Sans Frontières/Operational Center Brussels (2008) No cash, no care: How 'user fees' endanger health: An MSF briefing paper on financial barriers to healthcare. Available: http://www.msf.org/source/access/ 2008/NocashNocareMSFapril2008.pdf. Accessed 29 April 2009.
25. Ministry of Health Eritrea (2007) Malaria control in Eritrea: A success story. Available: http://www.cid.harvard.edu/sustsci/events/workshops/ 08institutions/docs/Meky-2008-Malaria-Control-in-Eritrea.pdf. Accessed 29 April 2009.
26. Haines A, Sanders D, Lehmann U, Rowe AK, Lawn JE, et al. (2007) Achieving child survival goals: Potential contribution of community health workers. Lancet 369: 2121-2131.
27. Gilson L, Walt G, Heggenhougen K, Owuor-Omondi L, Perera M, et al. (1989) National community health worker programs: How can they be strengthened? J Public Health Policy 10: 518-532.
28. Berman PA, Gwatkin DR, Burger SE (1987) Community-based health workers: Head start or false start towards health for all? Soc Sci Med 25: 443-459.
29. Nsungwa-Sabiti J, Peterson S, Pariyo G, Ogwal-Okeng J, Petzold MG, et al. (2007) Home-based management of fever and malaria treatment practices in Uganda. Trans R Soc Trop Med Hyg 101: 1199-1207.
30. Sabot O, Yeung S, Pagnoni F, Gordon M, Petty N, et al. (2009) Distribution of artemisinin-based combination therapies through private sector channels: Lessons from four country case studies. Available: http://www.rff.org/RFF/Documents/RFF-DP-08-43-FINAL.pdf. Accessed 29 April 2009.
31. Kindermans J, Pilloy J, Olliaro P, Gomes M (2007) Ensuring sustained ACT production and reliable artemisinin supply. Malar J 6: 125.
32. World Health Organization (2008) Marketing of oral artemisinin monotherapies at country level. Available: http://www.who.int/malaria/pages/ performance/monotherapycountries.html. Accessed 29 April 2009.
33. Arrow K, Panosian C, Gelband H (2004) Saving lives, buying time: Economics of malaria drugs in an age of resistance. The National Academics Press. Available: http://www.nap.edu/openbook.php?isbn=0309092183. Accessed 29 April 2009.
34. Novartis (2006) Novartis announces initiative to improve access to state-of-the-art anti-malarial treatment Coartem. Available: http://cws.hugi-nonline.com/N/134323/PR/200609/1078440-5-2.html. Accessed 14 May 2009.
35. Novartis (2008) Novartis announces 20% average reduction in price of malaria drug Coartem to further accelerate access in malaria-endemic regions. Available: http://www.novartis.com/newsroom/media-releases/en/2008/1212224. shtml. Accessed 14 May 2009.
36. World Health Organization (2007) Procurement of artemether/lumefantrine (Coartem) through WHO. Available: http://www.who.int/malaria/cmc-upload/0/000/ 015/789/CoA-website5.pdf. Accessed 14 May 2009.
37. The Clinton Foundation (2008) Overview of new ACT pricing for CHAI Procurement Consortium. Available: http://www.clintonfoundation.org/download/? guid=01be402a-a573-102b-81f3-00304860f676. Accessed 14 May 2009.
38. sanofi/aventis-DNDi (2007) New, once-a-day fixed-dose combination against malaria now available. Available: http://www.actwithasaq.org/en/press.htm. Accessed 14 May 2009.
39. Bosman A (2008) Market dynamics of ACTs in the public sector. Global Malaria Programme, World Health Organization. Artemisinin Forum 2008; 25 November 2008; Guilin, China. Available: http://www.mmv.org/IMG/pdf/15-WHO-ACT- public-market.pdf. Accessed 15 May 2009.
40. Pilloy J (2008) Le marché de l'artemisinine. Projet Artepal, Réunion ReMed. Available: http://www.remed.org/Le-marche-de-l- artemisinine-Pilloy.pdf. Accessed 14 May 2009.